**Core tip:** Moonwort is a widely used Chinese herbal medicine. To date, multiple organ dysfunction and rhabdomyolysis caused by moonwort poisoning have not been reported. In this case report, we describe the effects of blood purification combined with symptomatic treatment in patients with multiple organ dysfunction and rhabdomyolysis caused by moonwort poisoning. Use of this treatment was effective and safe in these patients.

INTRODUCTION
============

Moonwort is a plant of the genus *Pteridaceae* and the genus *Pteridium*. Moonwort is widely distributed in Yunnan, Hubei, Zhejiang, and other provinces in China. It is a widely used Chinese herbal medicine, which has numerous pharmacological effects, such as relieving cough and preventing asthma\[[@B1],[@B2]\]. In some parts of China, residents have the habit of eating moonwort. However, the chemical composition of moonwort is complex and diverse. Its effective dose and toxic dose are unknown. To date, few studies have investigated moonwort poisoning\[[@B3]-[@B5]\]. The present report describes four cases of multiple organ dysfunction and rhabdomyolysis caused by moonwort poisoning.

CASE PRESENTATION
=================

Chief complaints
----------------

Among the four patients, one was an adult male, two were adult females, and one was a boy. The age range of the patients was 7--64 years. On October 22, 2018, the four patients developed symptoms such as vomiting, fatigue, and muscle aches and pain after eating a mixture of "herbal medicine" and herbal liquid.

History of past illness
-----------------------

These patients are members of the same family (Table [1](#T1){ref-type="table"}). Case 2 had a history of hypertension. The other cases had no particular medical history.

###### 

Patients' characteristics

  **Case**   **Age (yr)**   **Weight (kg)**   **Past medical history**   **Time since poisoning to symptoms, h**   **Dose of herbal liquid and medicine**
  ---------- -------------- ----------------- -------------------------- ----------------------------------------- ----------------------------------------
  Case 1     64             65                No                         6                                         200 mL + 20 g
  Case 2     60             51                Hypertension               6                                         150 mL + 10 g
  Case 3     36             53                No                         2                                         450 mL + 40 g
  Case 4     7              28                No                         4                                         100 mL + 10 g

Physical examination
--------------------

The patients visited the local hospital on the same day and were diagnosed with acute herbal poisoning. After receiving gastric lavage, laxative drugs, and other treatments, the symptoms were not relieved. The patients were subsequently transferred to our hospital on October 23. The four patients had typical vital signs. There were no abnormal signs on physical examination (Table [2](#T2){ref-type="table"}).

###### 

Vital signs on physical examination at admission to our emergency room

  **Case**   **Blood pressure (mmHg)**   **Pulse (beats/min)**   **Respiratory rate (breaths/min)**   **Temperature (ºC)**   **SpO~2~ (%)**
  ---------- --------------------------- ----------------------- ------------------------------------ ---------------------- ----------------
  Case 1     114/69                      93                      19                                   36                     96
  Case 2     167/77                      92                      26                                   37                     99
  Case 3     138/97                      110                     28                                   36.2                   95
  Case 4     124/80                      109                     24                                   37.2                   98

SpO~2~: Peripheral capillary oxygen saturation.

Laboratory examinations
-----------------------

Admission-related investigations revealed that all four patients had liver dysfunction and elevated cardiac enzymes. However, all four patients showed marked elevations in serum levels of cardiac troponin I, myoglobin, and creatine kinase (Table [3](#T3){ref-type="table"}). There were also mild increases in white blood cell count and neutrophil count (Table [3](#T3){ref-type="table"}). However, electrolyte analysis did not demonstrate hyperkalemia in any of the four patients (Table [3](#T3){ref-type="table"}).

###### 

Results of laboratory investigations after admission

                                            **Case**   **Day[1](#T3FN1){ref-type="table-fn"} 1**   **Day[1](#T3FN1){ref-type="table-fn"} 1 after treatment[2](#T3FN2){ref-type="table-fn"}**   **Day[1](#T3FN1){ref-type="table-fn"} 2 after treatment[2](#T3FN2){ref-type="table-fn"}**   **Day[1](#T3FN1){ref-type="table-fn"} 7**
  ----------------------------------------- ---------- ------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- -------------------------------------------
  K^+^, mmol/L                              Case 1     3.95                                        4.29                                                                                        3.39                                                                                        4.23
  Case 2                                    2.93       3.02                                        2.82                                                                                        3.59                                                                                        
  Case 3                                    3.33       3.72                                        3.33                                                                                        4.33                                                                                        
  Case 4                                    3.57       3.77                                        3.22                                                                                        4.09                                                                                        
  Ca^2+^, mmol/L                            Case 1     2.06                                        2.01                                                                                        1.97                                                                                        2.2
  Case 2                                    2.11       1.96                                        1.98                                                                                        2.19                                                                                        
  Case 3                                    2.08       2.02                                        2.05                                                                                        2.27                                                                                        
  Case 4                                    2.27       2.17                                        2.19                                                                                        2.39                                                                                        
  Na^+^, mmol/L                             Case 1     140.5                                       138.1                                                                                       139.3                                                                                       138.4
  Case 2                                    136.1      141                                         144.8                                                                                       146.6                                                                                       
  Case 3                                    140.3      138.3                                       143.9                                                                                       144.8                                                                                       
  Case 4                                    141.6      140.8                                       138.9                                                                                       140.9                                                                                       
  Cl^-^, mmol/L                             Case 1     106                                         103.2                                                                                       109.6                                                                                       102.3
  Case 2                                    103.4      108.5                                       113                                                                                         105                                                                                         
  Case 3                                    106        103.2                                       111.7                                                                                       104.2                                                                                       
  Case 4                                    100        104.6                                       100.3                                                                                       99.1                                                                                        
  Cardiac troponin I, ng/mL                 Case 1     0.26                                        0.14                                                                                        0.06                                                                                        0.03
  Case 2                                    0.44       0.32                                        0.04                                                                                        0.01                                                                                        
  Case 3                                    1.26       0.62                                        0.1                                                                                         0.04                                                                                        
  Case 4                                    0.94       0.48                                        0.08                                                                                        0.03                                                                                        
  Myoglobin, ng/mL                          Case 1     \> 1000                                     316.3                                                                                       102                                                                                         68
  Case 2                                    \> 1000    229                                         85                                                                                          57                                                                                          
  Case 3                                    \> 1000    468.7                                       70                                                                                          55                                                                                          
  Case 4                                    225.5      225.5                                       40                                                                                          29                                                                                          
  Creatine kinase isoenzyme, ng/mL          Case 1     \> 500                                      318.8                                                                                       40.8                                                                                        2
  Case 2                                    155.8      84.1                                        11.2                                                                                        3.4                                                                                         
  Case 3                                    \> 500     171.2                                       41.4                                                                                        2.6                                                                                         
  Case 4                                    489.5      489.5                                       116.6                                                                                       3.07                                                                                        
  Creatine kinase, U/L                      Case 1     47643                                       30233                                                                                       30028                                                                                       69
  Case 2                                    7039       5101                                        2796                                                                                        86                                                                                          
  Case 3                                    42251      28228                                       13446                                                                                       112                                                                                         
  Case 4                                    19350      5814                                        1458                                                                                        58                                                                                          
  White blood cell count, 10^9^/L           Case 1     11.17                                       12.41                                                                                       15.23                                                                                       9.05
  Case 2                                    13.14      13.03                                       12.93                                                                                       9.38                                                                                        
  Case 3                                    15.14      13.68                                       14                                                                                          9.11                                                                                        
  Case 4                                    11.22      10.67                                       11.74                                                                                       6.92                                                                                        
  Neutrophil count, 10^9^/L                 Case 1     9.39                                        11.82                                                                                       13.71                                                                                       6.2
  Case 2                                    10.56      12.14                                       11.51                                                                                       6.26                                                                                        
  Case 3                                    13.11      12.91                                       13.16                                                                                       6.07                                                                                        
  Case 4                                    8.54       9.43                                        8.85                                                                                        4.69                                                                                        
  Lymphocyte count, 10^9^/L                 Case 1     1.37                                        0.58                                                                                        1.13                                                                                        1.27
  Case 2                                    1.71       0.63                                        1.06                                                                                        2.66                                                                                        
  Case 3                                    1.59       0.7                                         0.69                                                                                        1.68                                                                                        
  Case 4                                    1.99       1                                           1.84                                                                                        1.61                                                                                        
  Monocyte count, 10^9^/L                   Case 1     0.37                                        0.01                                                                                        0.38                                                                                        0.39
  Case 2                                    0.86       0.26                                        0.35                                                                                        0.52                                                                                        
  Case 3                                    0.4        0.07                                        0.14                                                                                        0.58                                                                                        
  Case 4                                    0.62       0.21                                        1.02                                                                                        0.57                                                                                        
  Eosinophilic granulocyte count, 10^9^/L   Case 1     0.03                                        0                                                                                           0                                                                                           0
  Case 2                                    0.01       0                                           0                                                                                           0                                                                                           
  Case 3                                    0.04       0                                           0.01                                                                                        0.02                                                                                        
  Case 4                                    0.04       0.01                                        0.01                                                                                        0.03                                                                                        
  Basophilic granulocyte count, 10^9^/L     Case 1     0.01                                        0                                                                                           0.01                                                                                        0.01
  Case 2                                    0          0                                           0.01                                                                                        0.01                                                                                        
  Case 3                                    0          0                                           0                                                                                           0.01                                                                                        
  Case 4                                    0.03       0.02                                        0.02                                                                                        0.02                                                                                        
  Red blood cell count, 10^9^/L             Case 1     5.3                                         4.97                                                                                        4.71                                                                                        4.66
  Case 2                                    5.06       4.85                                        4.58                                                                                        4.04                                                                                        
  Case 3                                    4.88       4.75                                        4.66                                                                                        4                                                                                           
  Case 4                                    4.94       4.99                                        4.57                                                                                        4.7                                                                                         
  Blood platelet count, 10^9^/L             Case 1     264                                         185                                                                                         111                                                                                         127
  Case 2                                    178        135                                         108                                                                                         132                                                                                         
  Case 3                                    404        320                                         258                                                                                         273                                                                                         
  Case 4                                    364        335                                         313                                                                                         266                                                                                         
  Hemoglobin, g/L                           Case 1     163                                         154                                                                                         145                                                                                         141
  Case 2                                    148        145                                         136                                                                                         121                                                                                         
  Case 3                                    116        113                                         111                                                                                         117                                                                                         
  Case 4                                    135        135                                         125                                                                                         137                                                                                         

The day in our hospital.

Two hours after hemoperfusion/plasma exchange.

Imaging examinations
--------------------

Pulmonary computed tomography for the four patients showed different degrees of exudation. There were no abnormalities in renal function tests, routine urine tests, or the electrocardiogram in any of the four patients.

FINAL DIAGNOSIS
===============

Based on the clinical history, symptom pattern, and elevated levels of creatine kinase and myoglobin, the admission diagnosis was acute herbal poisoning, multiple organ dysfunction, and rhabdomyolysis\[[@B6],[@B7]\]. During treatment at our department, the family provided the fresh and complete plants of the "herbal medicine" consumed by the patients (Figure [1](#F1){ref-type="fig"}). After consulting the literature and relevant Chinese herbal medicine experts, the poison was identified as moonwort. Hence, the patients were diagnosed with acute moonwort poisoning, multiple organ dysfunction (heart, liver, and lung), and rhabdomyolysis.

![The entire moonwort plant.](WJCC-8-479-g001){#F1}

TREATMENT
=========

From the day of admission, all patients were treated with oxygen therapy, liver protecting agents, cardiac nutritional treatments, anti-oxidants, anti-inflammatory drugs, and methylprednisolone. The therapeutic dose of methylprednisolone was calculated based on the patient's body weight. After consent of the patient and their family members, cases 1, 2, and 3 underwent two sessions of hemoperfusion for 2 hours on the day of admission and the second day after admission. Due to the absence of a pediatric hemoperfusion device, case 4 received two sessions of plasma exchanges on the day of admission and the second day after admission (Table [4](#T4){ref-type="table"}). The methylprednisolone dose was gradually reduced on October 29. During the blood purification treatment, the patients did not develop complications such as hemorrhage or shock. After treatment, the patients' symptoms were gradually relieved, and there was no other discomfort. Blood test indicators slowly returned to normal (Figure [2](#F2){ref-type="fig"}, Table [3](#T3){ref-type="table"}). On October 30, all patients had recovered and were discharged.

![Laboratory results. ALT: Alanine aminotransferase (U/L); CK: Creatine kinase (U/mL); CTNI: Cardiac troponin I (ng/mL); LDH: Lactate dehydrogenase (U/mL); Myo: Myoglobin (ng/mL).](WJCC-8-479-g002){#F2}

###### 

Type and time of blood purification

  **Date**                                     **Case**          **Type**        **Time (h)**
  -------------------------------------------- ----------------- --------------- --------------
  2018.10.23[1](#T4FN1){ref-type="table-fn"}   Case 1            Hemoperfusion   2
  Case 2                                       Hemoperfusion     2               
  Case 3                                       Hemoperfusion     2               
  Case 4                                       Plasma exchange   2               
  2018.10.24[2](#T4FN2){ref-type="table-fn"}   Case 1            Hemoperfusion   2
  Case 2                                       Hemoperfusion     2               
  Case 3                                       Hemoperfusion     2               
  Case 4                                       Plasma exchange   2               

The second day after poisoning.

The third day after poisoning.

OUTCOME AND FOLLOW-UP
=====================

The four patients were followed at 30 d after discharge, and no further symptoms were reported. The treatment process and timeline are shown in Figure [3](#F3){ref-type="fig"}.

![The treatment process and timeline for the four patients.](WJCC-8-479-g003){#F3}

DISCUSSION
==========

Here, we have reported four cases of acute moonwort poisoning with multiple organ dysfunction (heart, liver, and lung) and rhabdomyolysis. The mechanism of toxic fern poisoning remains unclear. A previous study\[[@B8]\] found that moonwort contains flavonoids, plant proteins, cardiac glycosides, saponins, and phenols, but not alkaloids or oils. However, since no previous studies have identified which components of moonwort have the ability to induce rhabdomyolysis, it is not possible to draw any conclusions regarding the causative compound(s) in the four cases described here. At present, the identification of moonwort is mainly based on trait and microscopy. Zhou et al\[[@B9]\] reported a detailed analysis and description of the morphology of the moonwort plant. After a comparative review, the four patients were diagnosed with acute moonwort poisoning. The time to symptom onset was 2--6 h, and the disease course was 8 d. The clinical condition of the patients was worse than that described previously in the literature\[[@B3]-[@B5]\]. In these reports, acute moonwort poisoning caused damage to the liver, kidneys, and some other organs, but no lung injury or rhabdomyolysis occurred. The time to symptom onset was 2--8 h, and the patients recovered after symptomatic treatment within 72 h. The severity of our cases in comparison to those in previous reports may be related to factors such as a higher dose of moonwort, consumption during a different season, and different origin of the moonwort. The fertility of moonwort in different habitats is not the same\[[@B8]\], and the efficacy of moonwort has noticeable seasonal differences\[[@B10]\].

Rhabdomyolysis is an acquired or inherited clinical syndrome characterized by the destruction of skeletal muscle and release of intracellular constituents (such as myoglobin, enzymes, and electrolytes) that lead to a variety of systemic complications\[[@B6]\]. The causes of acquired rhabdomyolysis are varied and include trauma, intense exertion, ischemia, thermal injury, drugs, and toxins\[[@B6],[@B11]\]. Regardless of the underlying cause, direct injury to the skeletal muscle membrane or energy depletion results in an increase in intracellular calcium that activates proteases and apoptotic pathways, leading to the generation of oxygen free radicals, mitochondrial dysfunction, and cell death\[[@B12],[@B13]\]. Rhabdomyolysis typically presents with myalgia, weakness, and/or myoglobinuria, but an accurate diagnosis is facilitated by the detection of an elevated creatine kinase level\[[@B6],[@B7],[@B11]-[@B13]\]. Acute kidney injury, the most frequent systemic complication of rhabdomyolysis, occurs with an incidence of 10%--40% and is associated with a poor prognosis, especially if multiple organ failure is also present\[[@B6],[@B13]\]. Other complications include electrolyte disturbances (such as hyperkalemia), hypovolemia, compartment syndrome, and disseminated intravascular coagulation\[[@B13]\]. The management of rhabdomyolysis includes treatment of the underlying cause, infusion of fluids to correct hypovolemia and electrolyte disturbances, alkalinization of the urine with sodium bicarbonate, and decompression of muscle compartments\[[@B13],[@B14]\].

Rhabdomyolysis may be associated with hyperkalemia due to the loss of large quantities of intracellular K^+^ from the damaged skeletal muscle and the development of acute kidney injury\[[@B15]\]. It is essential that hyperkalemia is rapidly corrected because it can result in potentially life-threatening arrhythmia\[[@B6]\]. However, it was notable that none of the four patients in our study exhibited an elevated level of plasma K^+^ before treatment. This may have been due to the rapid initiation of treatment and the absence of renal injury in these patients, which allowed the kidneys to compensate for the loss of K^+^ from skeletal muscle.

There is no specific antidote for acute moonwort poisoning. Gastric lavage, purgative agents, protection of essential organ functions, scavenging of oxygen free radicals, and prevention of complications are recommended. The four patients in this report developed liver, heart, and lung dysfunction as well as rhabdomyolysis after acute moonwort poisoning. Their condition was more serious than that described in previous reports. Since moonwort contains various chemicals, we used repeated hemoperfusion or plasma exchange along with symptomatic treatment. Hemoperfusion can eliminate medium- and large-sized toxic molecules and is widely used in the treatment of acute poisoning in Asia. It has a good effect on various poisons, such as paraquat and organic phosphorus\[[@B16]\]. In previous studies, some patients with severe poisoning also underwent repeated hemoperfusion, and good therapeutic results were achieved\[[@B17]\]. Plasma exchange is less applicable than hemoperfusion in acute poisoning. However, the daily replacement of up to 1--2 times the patient\'s plasma volume until symptom relief is achieved can effectively reduce the damage caused by the poison\[[@B18]\]. Acetylcysteine may also have an important role in the management of poisoning. Acetylcysteine is used as an anti-oxidant to prevent and treat cell damage, reduce apoptosis, and improve mitochondrial function\[[@B19]-[@B21]\]. Acetylcysteine can also improve the patient's renal metabolism and microcirculation\[[@B22]\]. These effects may be beneficial in alleviating multiple organ dysfunction and improving renal function after rhabdomyolysis.

CONCLUSION
==========

We have reported four cases of multiple organ dysfunction and rhabdomyolysis caused by moonwort poisoning. The patients were managed using blood purification techniques and symptomatic treatments. Their symptoms completely disappeared on the ninth day after poisoning. Blood purification combined with symptomatic treatment may be an effective method for acute moonwort poisoning. However, further research is required to confirm these findings.
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